Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer

Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer

Objective: Anaplastic thyroid cancer (ATC) is an aggressive disease associated with poor outcomes and resistance to therapies. Our study aim was to evaluate the activity of a combinatorial regimen of sandwich sequencing of pembrolizumab immunotherapy and hypofractionated radiotherapy (RT). Methods...

Full description

Bibliographic Details
Main Authors: Janice Ser Huey Tan, Timothy Kwang Yong Tay, Enya Hui Wen Ong, Michael Fehlings, Daniel Shao-Weng Tan, Nadiah Binte Sukma, Eileen Xueqin Chen, Jen-Hwei Sng, Connie Siew Poh Yip, Kok Hing Lim, Darren Wan-Teck Lim, Narayanan Gopalakrishna Iyer, Jacqueline Siok Gek Hwang, Melvin Lee Kiang Chua, Mei-Kim Ang
Format: Article
Language:English
Published: Bioscientifica 2024-02-01
Series:European Thyroid Journal
Subjects:
hypofractionated radiotherapy
immunotherapy
anaplastic thyroid cancer
quad-shot
Online Access:https://etj.bioscientifica.com/view/journals/etj/13/1/ETJ-23-0144.xml

Internet

https://etj.bioscientifica.com/view/journals/etj/13/1/ETJ-23-0144.xml

Similar Items